OTC Markets OTCQB - Delayed Quote • USD SANUWAVE Health, Inc. (SNWV) Follow Compare 26.34 -0.56 (-2.08%) At close: 3:14:18 PM EST All News Press Releases SEC Filings All SEC Filings Corporate Changes & Voting Matters Periodic Financial Reports Proxy Statements Tender Offer/Acquisition Reports Offering Registrations SANUWAVE Health Announces Preliminary Revenue Results for the Fourth Quarter 2024 (Ended December 31, 2024) SANUWAVE is pleased to announce preliminary revenues of $10.1 million to $10.3 million for the fourth quarter ended December 31, 2024. This represents the highest quarterly revenues in company history. Q4 2024 revenue increased between 44% and 47% c... SANUWAVE Health Appoints Industry Veteran Timothy Wern as Executive Vice President of Sales Wern Brings Strong Team Building, Growth, and Sales Skills to SANUWAVE After a Career of Growing Start Ups Into Mid and Large Sized Companies EDEN PRAIRIE, MN - January 13, 2025 (NEWMEDIAWIRE) - SANUWAVE Health, Inc. (the "Company" or " SANUWAVE ") (... SANUWAVE Announces Reverse Stock Split, Note and Warrant Exchange, and PIPE Offering 1-for-375 reverse stock split effective at market open today Exchanged $43.2 million in principal amount of convertible notes and warrants previously exercisable for approximately 1.7 billion pre-split shares for approximately 4.0 million post-split shares Closed $10.3 million equity only PIPE offering at $8.25 per share of common stock led by certain institutional investors, including AWM Investment Company, Inc., the investment adviser of the Special Situations Funds and with participation fro Sanuwave Health announces 1-for-375 reverse stock split SANUWAVE Health announced that the Company will implement a 1-for-375 reverse stock split of its outstanding common stock. The Company’s common stock will continue to trade under the symbol “SNWV” on the OTCQB and is expected to begin trading on a split-adjusted basis at the opening of the market on October 18, 2024, under a new CUSIP number, 80303D 305. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See the top stocks recommended SANUWAVE Announces Record Quarterly Revenues: Q2 FY2024 Financial Results Q2 2024 revenues were $7.2 million, up 53% from Q2 2023. This was an all-time quarterly record for the Company. Q2 2024 Gross Margin was 73%, vs 74% in Q2 2023 GAAP Operating Income was $2.0 Million Company Provides Guidance for Revenue Growth of 65-75% for Q3 2024 Versus Q3 2023 EDEN PRAIRIE, MN, Aug. 13, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, is pleased to provide its fi SANUWAVE Will Host a Conference Call on August 13, 2024 at 8:30 AM (ET) to Present Q2 Financial Results EDEN PRAIRIE, MN, Aug. 07, 2024 (GLOBE NEWSWIRE) -- SANUWAVE Health, Inc. (the "Company" or "SANUWAVE”) (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Tuesday, August 13, 2024, at 8:30 AM (ET) to present the Q2 2024 financial results. Telephone access to the call will be available by dialing the following numbers: Participant Dial-in Information Toll Free: 1-800-579-2543 Toll/International: 1-785-424-1789 Conference ID: SANUWAVE Health Announces Preliminary Revenue Results for the Second Quarter 2024 (Ended June 30, 2024) SANUWAVE is pleased to announce preliminary revenues of $7.0 million to $7.2 million for the second quarter ended June 30, 2024. This represents the highest quarterly revenues in company history. Q1 2024 revenue increased between 50% and 54% compared... SANUWAVE Announces Termination of Merger Agreement With SEP Acquisition Corp. Company to Pursue Alternate Plans for Capital Structure Improvement Including a Proposed Reverse Stock Split and a Note and Warrant Exchange Independent of a Merger Transaction EDEN PRAIRIE, MN - (NewMediaWire) - June 26, 2024 - SANUWAVE Health, Inc.... SANUWAVE Provides Corporate Update SANUWAVE pays off $6.3 million Celularity note and interest for $2.075 million SEPA merger outside date to be extended to June 30, 2024Combined entity has applied to list on Cboe BZX Exchange, Inc. EDEN PRAIRIE, MN - (NewMediaWire) - June 04, 2024 - ... SANUWAVE Will Host a Conference Call on June 4, 2024 at 8:30 AM (ET) to Provide a Corporate Update EDEN PRAIRIE, MN - (NewMediaWire) - June 03, 2024 - SANUWAVE Health, Inc. (the "Company" or "SANUWAVE") (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Tuesday, June 4, 2024, ... SANUWAVE Announces Q1 FY2024 Financial Results Q1 2024 revenues were $5.8 million, up 53% from Q1 2023 Q1 2024 gross margin was 73%, up 600bp from Q1 2023 Operating loss was $1.1 million for Q1 2024 compared to $2.0 million for Q1 2023 Company provides guidance for revenue growth of 45-55% for Q2... SANUWAVE Will Host a Conference Call on May 10, 2024 at 8:30 AM (ET) to Present Q1 Financial Results EDEN PRAIRIE, MN - (NewMediaWire) - May 07, 2024 - SANUWAVE Health, Inc. (the "Company" or "Sanuwave") (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, May 10, 2024, at... SANUWAVE Health Announces Preliminary Revenue Results for the First Quarter 2024 (Ended March 31, 2024) SANUWAVE is pleased to announce preliminary revenues of $5.7 million to $5.9 million for the first quarter ended March 31, 2024. This represents the highest Q1 revenues in company history.Q1 2024 revenue increased between 51% and 56% compared to Q1 2... SANUWAVE Health Appoints Industry Veteran Peter Sorensen as Chief Financial Officer Sorensen brings strong finance, forecasting, analysis, and capital markets experience as well as abilities in software, process automation, and human resources to SANUWAVEEDEN PRAIRIE, MN - (NewMediaWire) - April 01, 2024 - SANUWAVE Health, Inc. (the... SANUWAVE Announces Record Q4 and FY2023 Revenue SANUWAVE Announces Record Q4 and FY2023 Revenue SANUWAVE Will Host a Conference Call on March 22, 2024 at 8:30 AM (ET) to Present the Q4 and FY2023 Financial Results EDEN PRAIRIE, MN - (NewMediaWire) - March 20, 2024 - SANUWAVE Health, Inc. (the "Company" or "Sanuwave") (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, will host a live conference call on Friday, March 22, 2024... SANUWAVE Health Reports Stockholder Approval of SEPA Merger at Special Meeting of Stockholders At a special meeting of stockholders on February 21, 2024, SANUWAVE stockholders approved the business combination with SEP Acquisition Corp. by a vote of 798,379,869 "for" and 5,221,765 "against" with 71,525 abstaining70.5% of all shares eligible to... SANUWAVE Announces Special Meeting of Stockholders to Vote on Business Combination with SEP Acquisition Corp. (Nasdaq: SEPA) EDEN PRAIRIE, MN - (NewMediaWire) - January 22, 2024 - SANUWAVE Health, Inc. (the "Company" or "SANUWAVE") (OTCQB: SNWV), a leading provider of next-generation FDA-approved wound care products, today announced the Company is holding a special meeting... Performance Overview Trailing total returns as of 1/16/2025, which may include dividends or other distributions. Benchmark is S&P 500 Return SNWV S&P 500 YTD +17.07% +0.51% 1-Year +19.13% +24.11% 3-Year +19.13% +27.33%